The benefits of early treatment of diabetic patients

Fasting blood sugar is not high, but the increase in glucose after meals, which is a pre-diabetes, this medication should not it? In the past, doctors will advise patients to change lifestyles, such as diet, exercise, etc., but now, doctors will tell patients, lifestyle changes should be accompanied by the medication as soon as possible. Held in recent evaluation studies of acarbose (ACE) press conference, experts said abnormal glucose metabolism to early intervention, with the ultimate aim is not only to reduce blood sugar, but in order to reduce cardiovascular events, namely, protecting the heart .

There are three major advantages of early administration

According to the Chinese Medical Association Diabetes credits will be the latest epidemiological survey, prevalence of diabetes in Chinese urban residents was 11%, pre-diabetes prevalence rate was about 15%, that is, the community has a diabetes patient, almost about to have a into the ranks of pre-diabetes in patients with diabetes mellitus. According to experts, without intervention, about 1 / 3 of patients with pre-diabetes will develop diabetes.

And, if only fasting blood glucose, there is a large part of patients with abnormal glucose metabolism has been missed, especially in patients with pre-diabetes. For this reason, the University of Oxford Diabetes Center Waruiheman professor said that in 2007 the United States and Europe, "diabetes, pre-diabetes and cardiovascular disease guidelines" were recommended oral glucose tolerance test fasting blood glucose and postprandial glucose, with a view to early detection of Asymptomatic hyperglycemia and type 2 diabetes. Moreover, early intervention has become the United States and Europe specialist diabetes medical consensus.

If you can postprandial blood glucose under control, there are three major advantages: First, effective control of blood glucose and glycated hemoglobin, the second is to reduce pre-diabetes progressed to the risk of type 2 diabetes and the third is to reduce the patient's cardiovascular risk, which is the most important The.

Injury to the heart of postprandial hyperglycemia

Many patients, fasting plasma glucose test is normal, but the meal or received oral glucose tolerance test, you will find significantly more than normal blood sugar, which range between normal and diabetes is a state of pre-diabetes, also known as impaired glucose tolerance by the loss. Many people feel that do not is a slightly higher blood glucose and should be no harm. However, Karolinska professor at the University of Dayton Lasry said the heart of Europe investigations and surveys have shown that the heart of China, diabetes and myocardial infarction are a pair of lethal combinations. The coronary heart disease patients, abnormal glucose metabolism (including diabetes and pre-diabetes) than we have imagined universal. "A lot of studies have shown that postprandial hyperglycemia and cardiovascular disease incidence and mortality rates close." Visible, even if not yet developed to the stage of diabetes, pre-diabetes patient's heart also faces great risk.

Glucose a another job started to take medicine

Since the pre-diabetes should actively treated, how do drugs? Acarbose is currently the only applied to pre-diabetes drug, has been approved in 27 countries. There are a number of research evidence that the use of acarbose treatment in patients with the risk of diabetes and myocardial infarction were significantly reduced, is the only evidence of cardiovascular benefits of hypoglycemic drugs. Acarbose security is good, the burden of liver and kidney is small, not to increase the weight, does not produce low blood sugar in China has been widely used and accepted.

Read more informaiton, please click here!